Is Recombinant Growth Hormone Therapy Associated With Increased Intraoccular Pressure?

Recombinant growth hormone is a common therapy in the pediatric population. A number of associated side effects have been described. Several years ago, a case report was published concerning a child that was treated with RGH and developed acute glaucoma. To date no study has evaluated the connection.

Inclusion Criteria:

• Age 6-18 years
• treatment with recombinant growth hormone

Exclusion Criteria:

• Underlying Chronic diseases
• Family history of eye diseases
• elevated occular pressure prior to starting treatment